Raul Gainetdinov, Ph.D. - Publications

Affiliations: 
Italian Institute of Technology, Genoa, United States 

106 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Zhukov IS, Karpova IV, Krotova NA, Tissen IY, Demin KA, Shabanov PD, Budygin EA, Kalueff AV, Gainetdinov RR. Enhanced Aggression, Reduced Self-Grooming Behavior and Altered 5-HT Regulation in the Frontal Cortex in Mice Lacking Trace Amine-Associated Receptor 1 (TAAR1). International Journal of Molecular Sciences. 23. PMID 36430544 DOI: 10.3390/ijms232214066  0.307
2022 Efimova EV, Kuvarzin SR, Mor MS, Katolikova NV, Shemiakova TS, Razenkova V, Ptukha M, Kozlova AA, Murtazina RZ, Smirnova D, Veshchitskii AA, Merkulyeva NS, Volnova AB, Musienko PE, Korzhevskii DE, ... ... Gainetdinov RR, et al. Trace Amine-Associated Receptor 2 Is Expressed in the Limbic Brain Areas and Is Involved in Dopamine Regulation and Adult Neurogenesis. Frontiers in Behavioral Neuroscience. 16: 847410. PMID 35431833 DOI: 10.3389/fnbeh.2022.847410  0.348
2021 Sørensen G, Rickhag M, Leo D, Lycas MD, Ridderstrøm PH, Weikop P, Lilja JH, Rifes P, Herborg F, Woldbye D, Wörtwein G, Gainetdinov RR, Fink-Jensen A, Gether U. Disruption of the PDZ-domain binding motif of the dopamine transporter uniquely alters nanoscale distribution, dopamine homeostasis and reward motivation. The Journal of Biological Chemistry. 101361. PMID 34756883 DOI: 10.1016/j.jbc.2021.101361  0.363
2021 Zhukov IS, Kubarskaya LG, Karpova IV, Vaganova AN, Karpenko MN, Gainetdinov RR. Minor Changes in Erythrocyte Osmotic Fragility in Trace Amine-Associated Receptor 5 (TAAR5) Knockout Mice. International Journal of Molecular Sciences. 22. PMID 34298937 DOI: 10.3390/ijms22147307  0.306
2020 Sotnikova TD, Efimova EV, Gainetdinov RR. Enhanced Dopamine Transmission and Hyperactivity in the Dopamine Transporter Heterozygous Mice Lacking the D3 Dopamine Receptor. International Journal of Molecular Sciences. 21. PMID 33153031 DOI: 10.3390/ijms21218216  0.416
2020 Efimova EV, Kozlova AA, Razenkova V, Katolikova NV, Antonova KA, Sotnikova TD, Merkulyeva NS, Veshchitskii AS, Kalinina DS, Korzhevskii DE, Musienko PE, Kanov EV, Gainetdinov RR. Increased dopamine transmission and adult neurogenesis in trace amine-associated receptor 5 (TAAR5) knockout mice. Neuropharmacology. 182: 108373. PMID 33132188 DOI: 10.1016/j.neuropharm.2020.108373  0.378
2020 Kurzina NP, Aristova IY, Volnova AB, Gainetdinov RR. Deficit in working memory and abnormal behavioral tactics in dopamine transporter knockout rats during training in the 8-arm maze. Behavioural Brain Research. 390: 112642. PMID 32428629 DOI: 10.1016/j.bbr.2020.112642  0.305
2019 Lopachev A, Volnova A, Evdokimenko A, Abaimov D, Timoshina Y, Kazanskaya R, Lopacheva O, Deal A, Budygin E, Fedorova T, Gainetdinov R. Intracerebroventricular injection of ouabain causes mania-like behavior in mice through D2 receptor activation. Scientific Reports. 9: 15627. PMID 31666560 DOI: 10.1038/S41598-019-52058-Z  0.422
2019 Belov DR, Efimova EV, Fesenko ZS, Antonova KA, Kolodyazhny SF, Lakstygal AM, Gainetdinov RR. Putative Trace-Amine Associated Receptor 5 (TAAR5) Agonist α-NETA Increases Electrocorticogram Gamma-Rhythm in Freely Moving Rats. Cellular and Molecular Neurobiology. 40: 203-213. PMID 31385135 DOI: 10.1007/s10571-019-00716-1  0.319
2019 Efimova E, Katolikova N, Kozlova A, Antonova K, Murtazina R, Merkulyeva N, Veshchitskii A, Musienko P, Суханов ИМ, Espinoza S, Gainetdinov R. The role of trace amine associated receptor 5 (TAAR5) in mouse behavior and brain neurochemistry European Neuropsychopharmacology. 29. DOI: 10.1016/J.Euroneuro.2019.09.177  0.331
2019 Efimova E, Gerasimov A, Sukhanov I, Korenkova O, Antonova K, Ptuha M, Volnova A, Gainetdinov R. Identification of the agonist of trace amine-associated receptor 5 (TAAR5) and its action on brain physiology and neurochemistry European Neuropsychopharmacology. 29: S571-S572. DOI: 10.1016/J.Euroneuro.2018.11.848  0.333
2019 Kurzina N, Volnova A, Aristova I, Gainetdinov R. Effects of dopamine level on object recognition and formation of cognitive maps in rats European Neuropsychopharmacology. 29: S139-S140. DOI: 10.1016/J.Euroneuro.2018.11.253  0.336
2018 Lam VM, Mielnik CA, Baimel C, Beerepoot P, Espinoza S, Sukhanov I, Horsfall W, Gainetdinov RR, Borgland SL, Ramsey AJ, Salahpour A. Behavioral Effects of a Potential Novel TAAR1 Antagonist. Frontiers in Pharmacology. 9: 953. PMID 30233365 DOI: 10.3389/Fphar.2018.00953  0.304
2018 Espinoza S, Leo D, Sotnikova TD, Shahid M, Kääriäinen TM, Gainetdinov RR. Biochemical and Functional Characterization of the Trace Amine-Associated Receptor 1 (TAAR1) Agonist RO5263397. Frontiers in Pharmacology. 9: 645. PMID 29977204 DOI: 10.3389/fphar.2018.00645  0.342
2018 Meshalkina DA, Kysil EV, Antonova KA, Demin KA, Kolesnikova TO, Khatsko SL, Gainetdinov RR, Alekseeva PA, Kalueff AV. The Effects of Chronic Amitriptyline on Zebrafish Behavior and Monoamine Neurochemistry. Neurochemical Research. PMID 29740748 DOI: 10.1007/s11064-018-2536-5  0.322
2018 Cinque S, Zoratto F, Poleggi A, Leo D, Cerniglia L, Cimino S, Tambelli R, Alleva E, Gainetdinov RR, Laviola G, Adriani W. Behavioral Phenotyping of Dopamine Transporter Knockout Rats: Compulsive Traits, Motor Stereotypies, and Anhedonia. Frontiers in Psychiatry. 9: 43. PMID 29520239 DOI: 10.3389/Fpsyt.2018.00043  0.328
2018 Leo D, Sukhanov I, Zoratto F, Illiano P, Caffino L, Sanna F, Messa G, Emanuele M, Esposito A, Dorofeikova M, Budygin EA, Mus L, Efimova EE, Niello M, Espinoza S, ... ... Gainetdinov RR, et al. PRONOUNCED HYPERACTIVITY, COGNITIVE DYSFUNCTIONS AND BDNF DYSREGULATION IN DOPAMINE TRANSPORTER KNOCKOUT RATS. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 29348190 DOI: 10.1523/JNEUROSCI.1931-17.2018  0.345
2016 Mikhailova MA, Bass CE, Grinevich VP, Chappell AM, Deal AL, Bonin KD, Weiner JL, Gainetdinov RR, Budygin EA. Optogenetically-induced tonic dopamine release from VTA-nucleus accumbens projections inhibits reward consummatory behaviors. Neuroscience. PMID 27421228 DOI: 10.1016/J.Neuroscience.2016.07.006  0.334
2016 Fox ME, Mikhailova MA, Bass CE, Takmakov P, Gainetdinov RR, Budygin EA, Wightman RM. Cross-hemispheric dopamine projections have functional significance. Proceedings of the National Academy of Sciences of the United States of America. PMID 27298371 DOI: 10.1073/Pnas.1603629113  0.333
2016 Efimova EV, Gainetdinov RR, Budygin EA, Sotnikova TD. Dopamine transporter mutant animals: a translational perspective. Journal of Neurogenetics. 30: 5-15. PMID 27276191 DOI: 10.3109/01677063.2016.1144751  0.362
2016 Gurevich EV, Gainetdinov RR, Gurevich VV. G protein-coupled receptor kinases as regulators of dopamine receptor functions. Pharmacological Research. PMID 27178731 DOI: 10.1016/J.Phrs.2016.05.010  0.341
2016 Efimova E, Leo D, Sukhanov I, Illiano P, Mus L, Espinoza S, Sotnikova T, Hoener M, Gainetdinov R. Dopamine transporter knockout rats as a novel model of dopamine associated disorders European Neuropsychopharmacology. 26: S274. DOI: 10.1016/S0924-977X(16)31160-9  0.334
2015 Lam VM, Espinoza S, Gerasimov AS, Gainetdinov RR, Salahpour A. In-vivo pharmacology of Trace-Amine Associated Receptor 1. European Journal of Pharmacology. PMID 26093041 DOI: 10.1016/J.Ejphar.2015.06.026  0.359
2015 Espinoza S, Ghisi V, Emanuele M, Leo D, Sukhanov I, Sotnikova TD, Chieregatti E, Gainetdinov RR. Postsynaptic D2 dopamine receptor supersensitivity in the striatum of mice lacking TAAR1. Neuropharmacology. 93: 308-13. PMID 25721394 DOI: 10.1016/j.neuropharm.2015.02.010  0.369
2015 Beaulieu JM, Espinoza S, Gainetdinov RR. Dopamine receptors - IUPHAR Review 13. British Journal of Pharmacology. 172: 1-23. PMID 25671228 DOI: 10.1111/bph.12906  0.363
2015 Masoud ST, Vecchio LM, Bergeron Y, Hossain MM, Nguyen LT, Bermejo MK, Kile B, Sotnikova TD, Siesser WB, Gainetdinov RR, Wightman RM, Caron MG, Richardson JR, Miller GW, Ramsey AJ, et al. Increased expression of the dopamine transporter leads to loss of dopamine neurons, oxidative stress and l-DOPA reversible motor deficits. Neurobiology of Disease. 74: 66-75. PMID 25447236 DOI: 10.1016/J.Nbd.2014.10.016  0.36
2014 Sukhanov I, Espinoza S, Yakovlev DS, Hoener MC, Sotnikova TD, Gainetdinov RR. TAAR1-dependent effects of apomorphine in mice. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 17: 1683-93. PMID 24925023 DOI: 10.1017/S1461145714000509  0.356
2014 Steinkellner T, Mus L, Eisenrauch B, Constantinescu A, Leo D, Konrad L, Rickhag M, Sørensen G, Efimova EV, Kong E, Willeit M, Sotnikova TD, Kudlacek O, Gether U, Freissmuth M, ... ... Gainetdinov RR, et al. In vivo amphetamine action is contingent on αCaMKII. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2681-93. PMID 24871545 DOI: 10.1038/Npp.2014.124  0.357
2014 Daigle TL, Ferris MJ, Gainetdinov RR, Sotnikova TD, Urs NM, Jones SR, Caron MG. Selective deletion of GRK2 alters psychostimulant-induced behaviors and dopamine neurotransmission. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 39: 2450-62. PMID 24776686 DOI: 10.1038/Npp.2014.97  0.394
2014 Ferris MJ, Milenkovic M, Liu S, Mielnik CA, Beerepoot P, John CE, España RA, Sotnikova TD, Gainetdinov RR, Borgland SL, Jones SR, Ramsey AJ. Sustained N-methyl-d-aspartate receptor hypofunction remodels the dopamine system and impairs phasic signaling. The European Journal of Neuroscience. 40: 2255-63. PMID 24754704 DOI: 10.1111/Ejn.12594  0.376
2014 Cagniard B, Sotnikova TD, Gainetdinov RR, Zhuang X. The dopamine transporter expression level differentially affects responses to cocaine and amphetamine. Journal of Neurogenetics. 28: 112-21. PMID 24673634 DOI: 10.3109/01677063.2014.908191  0.343
2014 Leo D, Mus L, Espinoza S, Hoener MC, Sotnikova TD, Gainetdinov RR. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors. Neuropharmacology. 81: 283-91. PMID 24565640 DOI: 10.1016/j.neuropharm.2014.02.007  0.383
2014 Lavoie J, Illiano P, Sotnikova TD, Gainetdinov RR, Beaulieu JM, Hébert M. The electroretinogram as a biomarker of central dopamine and serotonin: potential relevance to psychiatric disorders. Biological Psychiatry. 75: 479-86. PMID 23305992 DOI: 10.1016/J.Biopsych.2012.11.024  0.304
2013 Medvedev IO, Ramsey AJ, Masoud ST, Bermejo MK, Urs N, Sotnikova TD, Beaulieu JM, Gainetdinov RR, Salahpour A. D1 dopamine receptor coupling to PLCβ regulates forward locomotion in mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 18125-33. PMID 24227722 DOI: 10.1523/Jneurosci.2382-13.2013  0.365
2012 Managò F, Espinoza S, Salahpour A, Sotnikova TD, Caron MG, Premont RT, Gainetdinov RR. The role of GRK6 in animal models of Parkinson's disease and L-DOPA treatment. Scientific Reports. 2: 301. PMID 22393477 DOI: 10.1038/Srep00301  0.333
2012 Meck WH, Cheng RK, MacDonald CJ, Gainetdinov RR, Caron MG, Cevik MÖ. Gene-dose dependent effects of methamphetamine on interval timing in dopamine-transporter knockout mice. Neuropharmacology. 62: 1221-9. PMID 21296093 DOI: 10.1016/J.Neuropharm.2011.01.042  0.494
2011 Beaulieu JM, Del'guidice T, Sotnikova TD, Lemasson M, Gainetdinov RR. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Frontiers in Molecular Neuroscience. 4: 38. PMID 22065948 DOI: 10.3389/fnmol.2011.00038  0.344
2011 Espinoza S, Salahpour A, Masri B, Sotnikova TD, Messa M, Barak LS, Caron MG, Gainetdinov RR. Functional interaction between trace amine-associated receptor 1 and dopamine D2 receptor. Molecular Pharmacology. 80: 416-25. PMID 21670104 DOI: 10.1124/Mol.111.073304  0.367
2011 Revel FG, Moreau JL, Gainetdinov RR, Bradaia A, Sotnikova TD, Mory R, Durkin S, Zbinden KG, Norcross R, Meyer CA, Metzler V, Chaboz S, Ozmen L, Trube G, Pouzet B, et al. TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity. Proceedings of the National Academy of Sciences of the United States of America. 108: 8485-90. PMID 21525407 DOI: 10.1073/Pnas.1103029108  0.372
2011 Beaulieu JM, Gainetdinov RR. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacological Reviews. 63: 182-217. PMID 21303898 DOI: 10.1124/pr.110.002642  0.343
2010 Sotnikova TD, Beaulieu JM, Espinoza S, Masri B, Zhang X, Salahpour A, Barak LS, Caron MG, Gainetdinov RR. The dopamine metabolite 3-methoxytyramine is a neuromodulator. Plos One. 5: e13452. PMID 20976142 DOI: 10.1371/Journal.Pone.0013452  0.392
2009 Ghisi V, Ramsey AJ, Masri B, Gainetdinov RR, Caron MG, Salahpour A. Reduced D2-mediated signaling activity and trans-synaptic upregulation of D1 and D2 dopamine receptors in mice overexpressing the dopamine transporter. Cellular Signalling. 21: 87-94. PMID 18929645 DOI: 10.1016/J.Cellsig.2008.09.011  0.382
2008 Sotnikova TD, Zorina OI, Ghisi V, Caron MG, Gainetdinov RR. Trace amine associated receptor 1 and movement control. Parkinsonism & Related Disorders. 14: S99-102. PMID 18585080 DOI: 10.1016/j.parkreldis.2008.04.006  0.353
2008 Salahpour A, Ramsey AJ, Medvedev IO, Kile B, Sotnikova TD, Holmstrand E, Ghisi V, Nicholls PJ, Wong L, Murphy K, Sesack SR, Wightman RM, Gainetdinov RR, Caron MG. Increased amphetamine-induced hyperactivity and reward in mice overexpressing the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 105: 4405-10. PMID 18347339 DOI: 10.1073/Pnas.0707646105  0.382
2008 Gainetdinov RR. Dopamine transporter mutant mice in experimental neuropharmacology. Naunyn-Schmiedeberg's Archives of Pharmacology. 377: 301-13. PMID 18057916 DOI: 10.1007/s00210-007-0216-0  0.393
2007 Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends in Pharmacological Sciences. 28: 166-72. PMID 17349698 DOI: 10.1016/j.tips.2007.02.006  0.311
2007 Beaulieu JM, Tirotta E, Sotnikova TD, Masri B, Salahpour A, Gainetdinov RR, Borrelli E, Caron MG. Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 881-5. PMID 17251429 DOI: 10.1523/Jneurosci.5074-06.2007  0.321
2007 Costa RM, Gutierrez R, de Araujo IE, Coelho MR, Kloth AD, Gainetdinov RR, Caron MG, Nicolelis MA, Simon SA. Dopamine levels modulate the updating of tastant values. Genes, Brain, and Behavior. 6: 314-20. PMID 16848782 DOI: 10.1111/J.1601-183X.2006.00257.X  0.347
2006 Caron MG, Gainetdinov RR. Dopamine: from pharmacology to molecular biology and back. Wiener Klinische Wochenschrift. 118: 565-8. PMID 17136328 DOI: 10.1007/s00508-006-0735-6  0.31
2006 Cyr M, Sotnikova TD, Gainetdinov RR, Caron MG. Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 20: 2541-3. PMID 17065224 DOI: 10.1096/fj.06-6533fje  0.385
2006 Costa RM, Lin SC, Sotnikova TD, Cyr M, Gainetdinov RR, Caron MG, Nicolelis MA. Rapid alterations in corticostriatal ensemble coordination during acute dopamine-dependent motor dysfunction. Neuron. 52: 359-69. PMID 17046697 DOI: 10.1016/j.neuron.2006.07.030  0.307
2006 Sotnikova TD, Caron MG, Gainetdinov RR. DDD mice, a novel acute mouse model of Parkinson's disease. Neurology. 67: S12-7. PMID 17030735  0.342
2006 Beaulieu JM, Sotnikova TD, Gainetdinov RR, Caron MG. Paradoxical striatal cellular signaling responses to psychostimulants in hyperactive mice. The Journal of Biological Chemistry. 281: 32072-80. PMID 16954211 DOI: 10.1074/jbc.M606062200  0.356
2006 Sasaki A, Sotnikova TD, Gainetdinov RR, Jarvis ED. Social context-dependent singing-regulated dopamine. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 9010-4. PMID 16943558 DOI: 10.1523/JNEUROSCI.1335-06.2006  0.321
2006 Sotnikova TD, Beaulieu JM, Gainetdinov RR, Caron MG. Molecular biology, pharmacology and functional role of the plasma membrane dopamine transporter. Cns & Neurological Disorders Drug Targets. 5: 45-56. PMID 16613553 DOI: 10.2174/187152706784111579  0.338
2005 Beaulieu JM, Sotnikova TD, Marion S, Lefkowitz RJ, Gainetdinov RR, Caron MG. An Akt/beta-arrestin 2/PP2A signaling complex mediates dopaminergic neurotransmission and behavior. Cell. 122: 261-73. PMID 16051150 DOI: 10.1016/j.cell.2005.05.012  0.323
2005 Sotnikova TD, Beaulieu JM, Barak LS, Wetsel WC, Caron MG, Gainetdinov RR. Dopamine-independent locomotor actions of amphetamines in a novel acute mouse model of Parkinson disease. Plos Biology. 3: e271. PMID 16050778 DOI: 10.1371/Journal.Pbio.0030271  0.397
2004 Budygin EA, Brodie MS, Sotnikova TD, Mateo Y, John CE, Cyr M, Gainetdinov RR, Jones SR. Dissociation of rewarding and dopamine transporter-mediated properties of amphetamine. Proceedings of the National Academy of Sciences of the United States of America. 101: 7781-6. PMID 15136721 DOI: 10.1073/pnas.0401418101  0.386
2004 Beaulieu JM, Sotnikova TD, Yao WD, Kockeritz L, Woodgett JR, Gainetdinov RR, Caron MG. Lithium antagonizes dopamine-dependent behaviors mediated by an AKT/glycogen synthase kinase 3 signaling cascade. Proceedings of the National Academy of Sciences of the United States of America. 101: 5099-104. PMID 15044694 DOI: 10.1073/Pnas.0307921101  0.331
2004 Powell SB, Lehmann-Masten VD, Paulus MP, Gainetdinov RR, Caron MG, Geyer MA. MDMA "ecstasy" alters hyperactive and perseverative behaviors in dopamine transporter knockout mice. Psychopharmacology. 173: 310-7. PMID 14747902 DOI: 10.1007/S00213-003-1765-7  0.326
2004 Barr AM, Lehmann-Masten V, Paulus M, Gainetdinov RR, Caron MG, Geyer MA. The selective serotonin-2A receptor antagonist M100907 reverses behavioral deficits in dopamine transporter knockout mice. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 29: 221-8. PMID 14603268 DOI: 10.1038/Sj.Npp.1300343  0.331
2003 Cyr M, Beaulieu JM, Laakso A, Sotnikova TD, Yao WD, Bohn LM, Gainetdinov RR, Caron MG. Sustained elevation of extracellular dopamine causes motor dysfunction and selective degeneration of striatal GABAergic neurons. Proceedings of the National Academy of Sciences of the United States of America. 100: 11035-40. PMID 12958210 DOI: 10.1073/Pnas.1831768100  0.34
2003 Gainetdinov RR, Bohn LM, Sotnikova TD, Cyr M, Laakso A, Macrae AD, Torres GE, Kim KM, Lefkowitz RJ, Caron MG, Premont RT. Dopaminergic supersensitivity in G protein-coupled receptor kinase 6-deficient mice. Neuron. 38: 291-303. PMID 12718862 DOI: 10.1016/S0896-6273(03)00192-2  0.369
2002 Joseph JD, Wang YM, Miles PR, Budygin EA, Picetti R, Gainetdinov RR, Caron MG, Wightman RM. Dopamine autoreceptor regulation of release and uptake in mouse brain slices in the absence of D(3) receptors. Neuroscience. 112: 39-49. PMID 12044470 DOI: 10.1016/S0306-4522(02)00067-2  0.39
2002 Raevskii KS, Gainetdinov RR, Budygin EA, Mannisto P, Wightman M. Dopaminergic transmission in the rat striatum in vivo in conditions of pharmacological modulation. Neuroscience and Behavioral Physiology. 32: 183-8. PMID 11942697 DOI: 10.1023/A:1013931609942  0.36
2001 Miller GW, Wang YM, Gainetdinov RR, Caron MG. Dopamine transporter and vesicular monoamine transporter knockout mice : implications for Parkinson's disease. Methods in Molecular Medicine. 62: 179-90. PMID 21318776 DOI: 10.1385/1-59259-142-6:179  0.317
2001 Gainetdinov RR, Mohn AR, Bohn LM, Caron MG. Glutamatergic modulation of hyperactivity in mice lacking the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 98: 11047-54. PMID 11572967 DOI: 10.1073/Pnas.191353298  0.419
2001 Sotnikova TD, Gainetdinov RR, Grekhova TV, Rayevsky KS. Effects of intrastriatal infusion of D2 and D3 dopamine receptor preferring antagonists on dopamine release in rat dorsal striatum (in vivo microdialysis study) Pharmacological Research. 43: 283-290. PMID 11401421 DOI: 10.1006/phrs.2000.0773  0.352
2001 Budygin EA, Phillips PE, Robinson DL, Kennedy AP, Gainetdinov RR, Wightman RM. Effect of acute ethanol on striatal dopamine neurotransmission in ambulatory rats. The Journal of Pharmacology and Experimental Therapeutics. 297: 27-34. PMID 11259524  0.316
2001 Zhuang X, Oosting RS, Jones SR, Gainetdinov RR, Miller GW, Caron MG, Hen R. Hyperactivity and impaired response habituation in hyperdopaminergic mice. Proceedings of the National Academy of Sciences of the United States of America. 98: 1982-7. PMID 11172062 DOI: 10.1073/pnas.98.4.1982  0.399
2000 Walker JKL, Gainetdinov RR, Mangel AW, Caron MG, Shetzline MA. Mice lacking the dopamine transporter display altered regulation of distal colonic motility American Journal of Physiology - Gastrointestinal and Liver Physiology. 279: G311-G318. PMID 10915639  0.346
2000 Xu F, Gainetdinov RR, Wetsel WC, Jones SR, Bohn LM, Miller GW, Wang YM, Caron MG. Mice lacking the norepinephrine transporter are supersensitive to psychostimulants. Nature Neuroscience. 3: 465-71. PMID 10769386 DOI: 10.1038/74839  0.358
1999 Huotari M, Gainetdinov R, Männistö PT. Microdialysis studies on the action of tolcapone on pharmacologically- elevated extracellular dopamine levels in conscious rats Pharmacology and Toxicology. 85: 233-238. PMID 10608486 DOI: 10.1111/J.1600-0773.1999.Tb02014.X  0.418
1999 Jones SR, Gainetdinov RR, Caron MG. Application of microdialysis and voltammetry to assess dopamine functions in genetically altered mice: correlation with locomotor activity. Psychopharmacology. 147: 30-2. PMID 10591864 DOI: 10.1007/s002130051137  0.32
1999 Miller GW, Gainetdinov RR, Levey AI, Caron MG. Dopamine transporters and neuronal injury. Trends in Pharmacological Sciences. 20: 424-9. PMID 10498956 DOI: 10.1016/S0165-6147(99)01379-6  0.329
1999 Gainetdinov RR, Jones SR, Caron MG. Functional hyperdopaminergia in dopamine transporter knock-out mice. Biological Psychiatry. 46: 303-11. PMID 10435196 DOI: 10.1016/S0006-3223(99)00122-5  0.386
1999 Jones SR, Gainetdinov RR, Hu XT, Cooper DC, Wightman RM, White FJ, Caron MG. Loss of autoreceptor functions in mice lacking the dopamine transporter. Nature Neuroscience. 2: 649-55. PMID 10404198 DOI: 10.1038/10204  0.395
1999 Budygin EA, Gainetdinov RR, Kilpatrick MR, Rayevsky KS, Männistö PT, Wightman RM. Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. European Journal of Pharmacology. 370: 125-31. PMID 10323260 DOI: 10.1016/S0014-2999(99)00084-9  0.356
1999 Fumagalli F, Gainetdinov RR, Wang YM, Valenzano KJ, Miller GW, Caron MG. Increased methamphetamine neurotoxicity in heterozygous vesicular monoamine transporter 2 knock-out mice. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 19: 2424-31. PMID 10087057 DOI: 10.1523/Jneurosci.19-07-02424.1999  0.368
1999 Melnikova V, Orosco M, Calas A, Sapronova A, Gainetdinov R, Delhaye-Bouchaud N, Nicolaidis S, Rayevsky K, Ugrumov M. Dopamine turnover in the mediobasal hypothalamus in rat fetuses. Neuroscience. 89: 235-41. PMID 10051232 DOI: 10.1016/S0306-4522(98)00278-4  0.397
1999 Gainetdinov RR. DOPAMINE AND NOREPINEPHRINE TRANSPORTER MUTANT MICE AND COCAINE DEPENDENCE Behavioural Pharmacology. 10: S36. DOI: 10.1097/00008877-199908001-00090  0.321
1999 Budygin EA, Kilpatrick M, Gainetdinov RR, Rayevsky KS, Wightman RM. The effect of the dopamine re-uptake inhibitor GBR 12909 on dopaminergic neurotransmission in rat striatum in vivo Eksperimental'Naya I Klinicheskaya Farmakologiya. 62: 5-6.  0.323
1998 Rocha BA, Fumagalli F, Gainetdinov RR, Jones SR, Ator R, Giros B, Miller GW, Caron MG. Cocaine self-administration in dopamine-transporter knockout mice. Nature Neuroscience. 1: 132-7. PMID 10195128 DOI: 10.1038/381  0.311
1998 Gainetdinov RR, Jones SR, Fumagalli F, Wightman RM, Caron MG. Re-evaluation of the role of the dopamine transporter in dopamine system homeostasis. Brain Research. Brain Research Reviews. 26: 148-53. PMID 9651511 DOI: 10.1016/S0165-0173(97)00063-5  0.365
1998 Fumagalli F, Gainetdinov RR, Valenzano KJ, Caron MG. Role of dopamine transporter in methamphetamine-induced neurotoxicity: Evidence from mice lacking the transporter Journal of Neuroscience. 18: 4861-4869. PMID 9634552  0.342
1998 Gainetdinov RR, Fumagalli F, Wang YM, Jones SR, Levey AI, Miller GW, Caron MG. Increased MPTP neurotoxicity in vesicular monoamine transporter 2 heterozygote knockout mice. Journal of Neurochemistry. 70: 1973-8. PMID 9572281 DOI: 10.1046/J.1471-4159.1998.70051973.X  0.316
1998 Jones SR, Gainetdinov RR, Jaber M, Giros B, Wightman RM, Caron MG. Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proceedings of the National Academy of Sciences of the United States of America. 95: 4029-34. PMID 9520487 DOI: 10.1073/Pnas.95.7.4029  0.384
1998 Jones SR, Gainetdinov RR, Wightman RM, Caron MG. Mechanisms of amphetamine action revealed in mice lacking the dopamine transporter. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 1979-86. PMID 9482784 DOI: 10.1523/Jneurosci.18-06-01979.1998  0.344
1998 Gainetdinov RR, Jones SR, Wightman RM, Carona MG. HYPERDOPAMINERGIC PHENOTYPE OF DOPAMINE TRANSPORTER KNOCKOUT MICE Behavioural Pharmacology. 9: S39. DOI: 10.1097/00008877-199808000-00075  0.356
1998 Rocha B, Fumagalli F, Gainetdinov R, Jones S, Ator R, Giros B, Miller G, Caron M. Erratum: Cocaine self-administration in dopamine-transporter knockout mice Nature Neuroscience. 1: 330-330. DOI: 10.1038/1152  0.371
1997 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Effects of a psychostimulant drug sydnocarb on rat brain dopaminergic transmission in vivo European Journal of Pharmacology. 340: 53-58. PMID 9527506 DOI: 10.1016/S0014-2999(97)01407-6  0.33
1997 Wang YM, Gainetdinov RR, Fumagalli F, Xu F, Jones SR, Bock CB, Miller GW, Wightman RM, Caron MG. Knockout of the vesicular monoamine transporter 2 gene results in neonatal death and supersensitivity to cocaine and amphetamine. Neuron. 19: 1285-96. PMID 9427251 DOI: 10.1016/S0896-6273(00)80419-5  0.372
1997 Gainetdinov RR, Fumagalli F, Jones SR, Caron MG. Dopamine transporter is required for in vivo MPTP neurotoxicity: evidence from mice lacking the transporter. Journal of Neurochemistry. 69: 1322-5. PMID 9282960 DOI: 10.1046/J.1471-4159.1997.69031322.X  0.348
1997 Bossé R, Fumagalli F, Jaber M, Giros B, Gainetdinov RR, Wetsel WC, Missale C, Caron MG. Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter. Neuron. 19: 127-38. PMID 9247269 DOI: 10.1016/S0896-6273(00)80353-0  0.325
1997 Rayevsky K, Kudrin V, Ganiev M, Gainetdinov R, Sotnikova T. P.2.086 Typical and atypical antipsychotics differ by their relation to various subtypes of brain dopamine receptor European Neuropsychopharmacology. 7: S219. DOI: 10.1016/S0924-977X(97)88720-2  0.329
1997 Rayevsky K, Sotnikova T, Gainetdinov R. Atypical antipsychotics affect prefferentially dopamine but not dopac extracellular levels in rat dorsal striatum Biological Psychiatry. 42: 174S. DOI: 10.1016/S0006-3223(97)87614-7  0.313
1997 Budygin EA, Gainetdinov RR, Raevsky KS, Li IH, Mannisto PT. Microdialysis of the effect of tolcapone in GBR-12909-induced blockade of dopamine uptake Eksperimental'Naya I Klinicheskaya Farmakologiya. 60: 10.  0.333
1997 Rayevsky KS, Gainetdinov RR, Sotnikova TD. Functional heterogeneity of brain dopamine recetors and effects of old and new antipsychotics Faseb Journal. 11: A212.  0.319
1996 Raevskii KS, Sotnikova TD, Gainetdinov RR. The brain dopaminergic systems: receptor heterogeneity, functional role and pharmacological regulation | Dofaminergicheskie sistemy mozga: retseptornaia geterogennost', funktsional'naia rol', farmakologicheskaia reguliatsiia Uspekhi Fiziologicheskikh Nauk. 27: 3-29. PMID 9019922  0.329
1996 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. In vivo evidence for preferential role of dopamine D3 receptor in the presynaptic regulation of dopamine release but not synthesis European Journal of Pharmacology. 308: 261-269. PMID 8858296 DOI: 10.1016/0014-2999(96)00300-7  0.342
1996 Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors subtype D3 predominantly regulate the liberation of dopamine in rat brain basal ganglia | Dofaminovye autoretseptory D3 podtipa preimushchestvenno reguliruiut vysvobozhdenie dofamina v bazal'nykh gangliiakh mozga krys Biulleten' Eksperimental'Noi Biologii I Meditsiny. 121: 430-434. PMID 8829459  0.309
1996 Gainetdinov RR, Raevskii KS. Substances increasing the extracellular content of dopamine in the striatum prevent the development of haloperidol catalepsy in rats Bulletin of Experimental Biology and Medicine. 121: 399-401.  0.307
1996 Sotnikova TD, Gainetdinov RR, Grekhova TV, Raevskii KS. Dopamine autoreceptors of subtype D3 regulate mainly dopamine release in the basal ganglia of rat brain Bulletin of Experimental Biology and Medicine. 121: 392-396.  0.339
1995 Rayevsky KS, Gainetdinov RR, Grekhova TV, Sotnikova TD. Regulation of dopamine release and metabolism in rat striatum in vivo: Effects of dopamine receptor antagonists Progress in Neuropsychopharmacology and Biological Psychiatry. 19: 1285-1303. PMID 8868210 DOI: 10.1016/0278-5846(95)00267-7  0.33
1995 Gainetdinov RR, Sotnikova TD, Grekhova TV, Rayevsky KS. Preferential role of D3 dopamine autoreceptor in regulation of dopamine release but not synthesis in nucleus accumbens and dorsal striatum of freely moving rats Behavioural Pharmacology. 6: 74. DOI: 10.1097/00008877-199505001-00088  0.316
1994 Gainetdinov RR, Grekhova TV, Sotnikova TD, Rayevsky KS. Dopamine D2 and D3 receptor preferring antagonists differentially affect striatal dopamine release and metabolism in conscious rats European Journal of Pharmacology. 261: 327-331. PMID 7813556 DOI: 10.1016/0014-2999(94)90125-2  0.344
Show low-probability matches.